Sun Pharma Corporate Overview

ANDA Pipeline - Significant ramp up ANDAS Filed and Approved (Cumulative) ANDA Approvals by Therapeutic Area 595 129 584 561 571 581 112 501 483 453 427 422 FY17 FY18 Cumulative Products Filed FY19 FY20 FY21 Cumulative Products Approved © Sun Pharmaceutical Industries Limited. All Rights Reserved. 67 62 48 48 31 19 15 14 15 14 Allergy Oncology Metabolism Antibiotic SUN PHARMA 51 Gastro Others (All data as of 31-March-2021) 20

View entire presentation